Best Growth Stocks To Watch Now - July 15th

Key Points

• MarketBeat identified five growth stocks to watch on July 15: Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Pattern Group. The list was based on the stocks with the highest dollar trading volume among growth names over the past several days.
• Prologis stands out as the global leader in logistics real estate, with a massive portfolio and development pipeline totaling about 1.2 billion square feet across 19 countries. The company is positioned in high-barrier, high-growth markets.
• The other names span diverse growth themes, including Teledyne’s industrial imaging and sensor technologies, Ascendis’ rare-disease biopharma pipeline, Hamilton Lane’s private equity investing, and Pattern Group’s AI-driven ecommerce optimization platform.

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Pattern Group are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares in companies that are expected to grow their revenue, earnings, or market share faster than the overall market or their industry. Investors often buy them because they believe the company’s rapid expansion will lead to strong future stock price gains, even though these stocks may pay little or no dividends and can be more volatile. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Read Our Latest Research Report on PLD

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

Read Our Latest Research Report on TDY

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Read Our Latest Research Report on ASND

Hamilton Lane (HLNE)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Read Our Latest Research Report on HLNE

Pattern Group (PTRN)

At Pattern, we are on a mission to help brands accelerate profitable growth on global ecommerce marketplaces. Today, our proprietary technology and on-demand experts operate across more than 60 marketplaces to increase product sales to consumers in more than 100 countries. Utilizing more than 46 trillion data points and sophisticated machine learning and artificial intelligence (“AI”) models, we strive to optimize and automate key levers of ecommerce growth, including advertising, content creation and management, pricing, forecasting and customer service.

Read Our Latest Research Report on PTRN

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.